Calton & Associates’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$245K Buy
746
+81
+12% +$29.1K 0.04% 367
2025
Q4
$234K Buy
665
+65
+11% +$23.7K 0.03% 389
2025
Q3
$222K Sell
600
-2
-0.3% -$773 0.03% 382
2025
Q2
$238K Buy
+602
New +$225K 0.04% 330
2022
Q2
Sell
-826
Closed -$220K 344
2022
Q1
$220K Sell
826
-618
-43% -$160K 0.07% 317
2021
Q4
$386K Sell
1,444
-214
-13% -$56.2K 0.1% 215
2021
Q3
$437K Sell
1,658
-341
-17% -$91.2K 0.1% 214
2021
Q2
$520K Buy
1,999
+186
+10% +$47.6K 0.1% 192
2021
Q1
$442K Buy
+1,813
New +$435K 0.09% 209
2020
Q3
Sell
-1,212
Closed -$218K 366
2020
Q2
$218K Buy
+1,212
New +$224K 0.05% 283
2020
Q1
Sell
-1,346
Closed -$283K 377
2019
Q4
$283K Buy
1,346
+366
+37% +$76K 0.06% 272
2019
Q3
$212K Buy
+980
New +$210K 0.05% 303
2018
Q2
Sell
-1,571
Closed -$253K 384
2018
Q1
$253K Buy
1,571
+56
+4% +$9.03K 0.07% 272
2017
Q4
$245K Buy
+1,515
New +$231K 0.06% 291

Other funds holding SYK

Calton & Associates's SYK Position: Q1 2026 in Review

Calton & Associates increased its Stryker (SYK) stake by 12% in Q1 2026, buying an estimated $29.1K and bringing the position to 746 shares worth $245K. The position accounts for 0.04% of the portfolio, ranked #367.

Calton & Associates first reported a position in SYK in Q4 2017 and has held it in 14 quarters since. The position peaked at $520K in Q2 2021. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Calton & Associates held 746 shares of Stryker worth $245K as of Q1 2026.
  • Calton & Associates bought 81 Stryker shares in Q1 2026, an estimated $29.1K.
  • Stryker made up 0.04% of Calton & Associates's portfolio in Q1 2026, its #367 holding.
  • Calton & Associates first reported a position in Stryker in Q4 2017 and has held it in 14 quarters since.
  • Calton & Associates's Stryker position peaked at $520K in Q2 2021.
  • 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Calton & Associates's 13F filing for Q1 2026, filed 13 May 2026.